ZMH: ZIMMER HLDGS INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 11 hrs, 19 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

ZIMMER HLDGS INC

ZMH

Stock price

68.02 0.21 0.31%

as of 01:04 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ZMH

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$3,897,500,000	11.5%	$773,200,000	7,600

Key Executives: ZMH

Name	Title	Officer Since
David C. Dvorak	CEO	5/1/07
James T. Crines	CFO	-
Dr. Cheryl R. Blanchard, Ph.D.	Chief Scientific Officer	-
Derek M. Davis	Chief Accounting Officer	-
Chad F. Phipps	General Counsel	-
Stephen H.L. Ooi	Geographical President	-
Robert A. Hagemann	Director	3/13/08
Dr. Cecil B. Pickett, Ph.D.	Director	3/13/08

View All Key Executives

David C. Dvorak, President and Chief Executive Officer of the company since May 1, 2007. Prior to that, Mr. Dvorak served as Group President, Global Businesses and Chief Legal Officer of Zimmer from December 2005. From October 2003 to December 2005, Mr. Dvorak served as Executive Vice President, Corporate Services, Chief Counsel and Secretary, as well as Chief Compliance Officer. Mr. Dvorak was appointed Corporate Secretary in February 2003. He... View Full Profile

David C. Dvorak

Mr. Ooi was appointed President, Asia Pacific of Zimmer Holdings in December 2005. He is responsible for overall operations in the Asia Pacific region, including responsibility for Japan. Following our acquisition of Centerpulse, Mr. Ooi served as President, Australasia from September 2003 to December 2005, where he was responsible for operations in Asia Pacific, excluding Japan. From September 2002 to September 2003, Mr. Ooi served as... View Full Profile

Stephen H.L. Ooi

Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated, or Quest, since November 2003. Prior to that, Mr. Hagemann served as Vice President and Chief Financial Officer of Quest from August 1998. Mr. Hagemann joined a predecessor company, Corning Life Sciences, Inc., a subsidiary of Quest's former parent, Corning Incorporated, in 1992, and held a variety of senior financial positions before being... View Full Profile

Robert A. Hagemann

Dr. Cecil B. Pickett, Ph.D., President, Research and Development of Biogen Idec Inc. since September 2006. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, most recently as a Corporate Senior Vice President of Schering Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received his B.Sc. in biology from... View Full Profile

Dr. Cecil B. Pickett, Ph.D.

Mr. Crines was appointed Executive Vice President, Finance and Chief Financial Officer of Zimmer Holdings on May 1, 2007. From December 2005 to April 2007, Mr. Crines served as Senior Vice President, Finance, Operations and Corporate Controller and Chief Accounting Officer. From October 2003 to December 2005, Mr. Crines served as Senior Vice President, Finance/Controller and Information Technology and from July 2001 to October 2003, he served as... View Full Profile

James T. Crines

Larry C. Glasscock, Chairman of WellPoint, Inc. since November 2005. Mr. Glasscock also served as President and Chief Executive Officer of WellPoint, Inc. from November 2004 (following the merger between Anthem, Inc. and WellPoint Health Networks Inc.) until his retirement from day-to-day operations in June 2007. Mr. Glasscock served as Chairman, President and Chief Executive Officer of Anthem, Inc. from May 2003 to November 2004 and served as... View Full Profile

Larry C. Glasscock

Dr. Blanchard was appointed Senior Vice President, Research and Development and Chief Scientific Officer of Zimmer Holdings in December 2005. She is responsible for global research, global development, global quality, orthobiologics, external research and emerging technologies. From October 2003 to December 2005, Dr. Blanchard served as Vice President, Corporate Research and Clinical Affairs and from August 2002 to October 2003, she served as... View Full Profile

Dr. Cheryl R. Blanchard, Ph.D.

Mr. Davis was appointed Vice President, Finance and Corporate Controller and Chief Accounting Officer of Zimmer Holdings in May 2007. He has responsibility for internal and external reporting, planning and analysis, and corporate and business unit accounting. From March 2006 to May 2007, Mr. Davis served as Director, Financial Planning and Accounting. From December 2003 to March 2006, Mr. Davis served as Director, Finance, Operations and... View Full Profile

Derek M. Davis

Arthur J. Higgins, Chairman of the Board of Management of Bayer HealthCare AG since January 2006 and Chairman of the Bayer HealthCare Executive Committee since July 2004. Prior to joining Bayer Healthcare, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to joining Enzon Pharmaceuticals, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of... View Full Profile

Arthur J. Higgins

Augustus A. White, III, M.D., Ph.D., Ellen and Melvin Gordon Professor of Medical Education, Professor of Orthopaedic Surgery, and former Master of the Oliver Wendell Holmes Society at the Harvard Medical School and Professor of Orthopaedic Surgery at the Harvard-MIT Division of Health Sciences and Technology; and Orthopaedic Surgeon-in-Chief, Emeritus, at the Beth Israel Deaconess Medical Center in Boston. Dr. White previously served as the... View Full Profile

Dr. Augustus A. White, III, M.D., Ph.D.

Stuart M. Essig, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation, or Integra, since December 1997. Prior to joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig had ten years of experience at Goldman Sachs serving as a senior mergers and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical... View Full Profile

Stuart M. Essig, Ph.D.

John L. McGoldrick, Senior Vice President, External Strategy Development, International AIDS Vaccine Initiative since May 2006. Mr. McGoldrick served as Executive Vice President of Bristol-Myers Squibb Company, or Bristol-Myers Squibb, from October 2005 until his retirement in April 2006. He held the position of Executive Vice President and General Counsel of Bristol-Myers Squibb from January 2000 to October 2005. Prior to that, he held the... View Full Profile

John L. McGoldrick

John L. McGoldrick, Senior Vice President, External Strategy Development, International AIDS Vaccine Initiative since May 2006. Mr. McGoldrick served as Executive Vice President of Bristol-Myers Squibb Company, or Bristol-Myers Squibb, from October 2005 until his retirement in April 2006. He held the position of Executive Vice President and General Counsel of Bristol-Myers Squibb from January 2000 to October 2005. Prior to that, he held the... View Full Profile

Sheryl L. Conley

Mr. Kramer was appointed President, U.S. Sales of Zimmer Holdings in December 2005. He is responsible for our sales activities throughout the United States. From August 2004 to December 2005, Mr. Kramer served as President, Americas. From October 2003 to August 2004, Mr. Kramer served as Vice President, U.S. Sales and from 2001 to October 2003, he was our Area Vice President for the Southeast region of the United States.... View Full Profile

Jon E. Kramer

Mr. Phipps was appointed Senior Vice President, General Counsel and Secretary of Zimmer Holdings in May 2007. He has global responsibility for our legal affairs and he serves as Secretary to the Board of Directors. From December 2005 to May 2007, Mr. Phipps served as Associate General Counsel and Corporate Secretary and from September 2003 to December 2005, he served as Associate Counsel and Assistant Secretary. Prior to joining us, Mr. Phipps... View Full Profile

Chad F. Phipps

Mr. Melzi was appointed Chairman, Europe, Middle East and Africa of Zimmer Holdings in October 2003. He is responsible for the sales, marketing and distribution of products in the European, Middle Eastern and African regions. From March 2000 to October 2003, Mr. Melzi served as President, Europe/MEA.... View Full Profile

Bruno A. Melzi

Mr. Melzi was appointed Chairman, Europe, Middle East and Africa of Zimmer Holdings in October 2003. He is responsible for the sales, marketing and distribution of products in the European, Middle Eastern and African regions. From March 2000 to October 2003, Mr. Melzi served as President, Europe/MEA.... View Full Profile

J. Raymond Elliott

Mr. Melzi was appointed Chairman, Europe, Middle East and Africa of Zimmer Holdings in October 2003. He is responsible for the sales, marketing and distribution of products in the European, Middle Eastern and African regions. From March 2000 to October 2003, Mr. Melzi served as President, Europe/MEA.... View Full Profile

Sam R. Leno

Top Competitors: ZMH

View Detailed Competitors Chart

Insider Trends: ZMH
Sentiment for ZMH is NEUTRAL
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: ZMH

Date	Name	Shares	Transaction Type	Market Value
05/16/08	OOI STEPHEN HONG LIANG	20,362	Sale	$1.43 M
05/16/08	OOI STEPHEN HONG LIANG	20,362	Exercise of Stock Options	$538,718.42
04/28/08	OOI STEPHEN HONG LIANG	20,362	Planned Sale	$1.52 M

View All Insider Activity

Ownership Breakdown : ZMH

Large Block Holder Type	Number
Institutions	987.00
Mutual Fund	1,367.00
Other Major	13.00

Full Details

Indices : ZMH

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	690.92	-0.56 -0.08%
$INX	S&P 500 Index	—	——%

View all Indices that include ZMH

Short Interest Volume: ZMH

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	2.50
Float	231.24 M

Short Interest as % of Float	1.40
Average Daily Volume	1.50 M
Outstanding Shares	231.49 M

Full Details

SEC Filings: ZMH

Accepted Date	Description
07/02/2008	SEC Filing: Insider Buy/Sell
07/02/2008	SEC Filing: Insider Buy/Sell
07/02/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

ZIMMER HLDGS INC

ZMH

Stock price

68.02 0.21 0.31%

as of 01:04 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ZMH

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The ZIMMER HLDGS INC profile at AOL Money & Finance provides you with all the zmh investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

ZIMMER HLDGS INC

ZMH

Stock price

Extended Hours

Analyst Consensus

ZIMMER HLDGS INC Profile

Key Executives: ZMH

Top Competitors: ZMH

Insider Trends: ZMH

Insider Transactions: ZMH

Ownership Breakdown : ZMH

Indices : ZMH

Short Interest Volume: ZMH

SEC Filings: ZMH

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials